Literature DB >> 17375119

Folate status and S-adenosylmethionine/S-adenosylhomocysteine ratio in colorectal adenocarcinoma in humans.

E Alonso-Aperte1, M P González, R Póo-Prieto, G Varela-Moreiras.   

Abstract

OBJECTIVES: This study reports the influence of colorectal neoplasia on methylation intermediates and folate concentrations in human colonic mucosa, as well as systemic measures of folate status, to examine biomarkers and possible mechanisms of folate-related carcinogenesis.
SUBJECTS: A total of 47 patients were selected from those previously diagnosed with adenocarcinoma of the colorectum undergoing surgery. For each individual, we obtained a biopsy of the adenocarcinoma and a biopsy of normal appearing mucosa, to perform an intra-individual comparison.
RESULTS: The 'methylation' ratio (S-adenosylmethionine/S-adenosylhomocysteine (SAH)) was lower in pathological tissue vs normal mucosa (P=0.08), mainly due to a much higher SAH concentration (P<0.005). Colonic folate concentration was significantly diminished in malignant tissue (P<0.0001). Plasma homocysteine concentration was within the normal to high range, and folate and vitamin B12 plasma concentrations were within the low to normal range as compared with normative values.
CONCLUSION: Our results contribute to the hypothesis that altered DNA methylation and methyl metabolism is associated with colorectal neoplasia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17375119     DOI: 10.1038/sj.ejcn.1602722

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  9 in total

1.  Relationships among biomarkers of one-carbon metabolism.

Authors:  Will D King; Vikki Ho; Linda Dodds; Sherry L Perkins; R Ian Casson; Thomas E Massey
Journal:  Mol Biol Rep       Date:  2012-04-24       Impact factor: 2.316

2.  Global DNA hypomethylation of colorectal tumours detected in tissue and liquid biopsies may be related to decreased methyl-donor content.

Authors:  Krisztina A Szigeti; Alexandra Kalmár; Orsolya Galamb; Gábor Valcz; Barbara K Barták; Zsófia B Nagy; Sára Zsigrai; Ildikó Felletár; Árpád V Patai; Tamás Micsik; Márton Papp; Eszter Márkus; Zsolt Tulassay; Peter Igaz; István Takács; Béla Molnár
Journal:  BMC Cancer       Date:  2022-06-02       Impact factor: 4.638

3.  Germline polymorphisms in the one-carbon metabolism pathway and DNA methylation in colorectal cancer.

Authors:  Aditi Hazra; Charles S Fuchs; Takako Kawasaki; Gregory J Kirkner; David J Hunter; Shuji Ogino
Journal:  Cancer Causes Control       Date:  2010-03       Impact factor: 2.506

4.  Effects of methionine synthase and methylenetetrahydrofolate reductase gene polymorphisms on markers of one-carbon metabolism.

Authors:  Vikki Ho; Thomas E Massey; Will D King
Journal:  Genes Nutr       Date:  2013-10-08       Impact factor: 5.523

5.  Oxidative Stress and Polymorphism in MTHFR SNPs (677 and 1298) in Paternal Sperm DNA is Associated with an Increased Risk of Retinoblastoma in Their Children: A Case-Control Study.

Authors:  Shilpa Bisht; Bhavna Chawla; Rima Dada
Journal:  J Pediatr Genet       Date:  2018-07-11

6.  A potential epigenetic marker mediating serum folate and vitamin B12 levels contributes to the risk of ischemic stroke.

Authors:  Loo Keat Wei; Heidi Sutherland; Anthony Au; Emily Camilleri; Larisa M Haupt; Siew Hua Gan; Lyn R Griffiths
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

7.  Peiminine inhibits colorectal cancer cell proliferation by inducing apoptosis and autophagy and modulating key metabolic pathways.

Authors:  Zhi Zheng; Liting Xu; Shuofeng Zhang; Wuping Li; Fangfang Tou; Qinsi He; Jun Rao; Qiang Shen
Journal:  Oncotarget       Date:  2017-07-18

Review 8.  H3K4 Methylation in Aging and Metabolism.

Authors:  Chia-Ling Hsu; Yi-Chen Lo; Cheng-Fu Kao
Journal:  Epigenomes       Date:  2021-06-18

9.  Pre- and Post-Resection Urine Metabolic Profiles of Bladder Cancer Patients: Results of Preliminary Studies on Time Series Metabolomics Analysis.

Authors:  Julia Jacyna; Marta Kordalewska; Małgorzata Artymowicz; Marcin Markuszewski; Marcin Matuszewski; Michał J Markuszewski
Journal:  Cancers (Basel)       Date:  2022-02-25       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.